|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000066135 |
Summary for KDM4A |
Gene summary |
| Gene information | Ensembl ID | ENSG00000066135 | Gene symbol | KDM4A |
| Gene name | lysine demethylase 4A | |
| HGNC | 22978 | |
| Entrez ID | 9682 | |
| Gene type | protein_coding | |
| Synonyms | KDM4A|KIAA0677|JHDM3A|TDRD14A | |
| UniProtAcc | O75164 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for KDM4A |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for KDM4A |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for KDM4A |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg00946598 | chr1:43651422 | CGI:chr1:43649945-43650638 | promoter,gene body | 5.89e-01 | 7.65e-01 | -2.63e+00 | 8.61e-03 | 2.53e-02 | -1.76e-01 |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| KIRC | cg10958452 | chr1:43648675 | CGI:chr1:43649945-43650638 | promoter | 8.30e-01 | 9.41e-01 | -4.16e+00 | 3.16e-05 | 7.43e-05 | -1.11e-01 |
| KIRC | cg17737314 | chr1:43648684 | CGI:chr1:43649945-43650638 | promoter | 7.31e-01 | 9.07e-01 | -2.58e+00 | 9.91e-03 | 1.18e-02 | -1.76e-01 |
| HNSC | cg10958452 | chr1:43648675 | CGI:chr1:43649945-43650638 | promoter | 5.61e-01 | 7.57e-01 | -2.09e+00 | 3.69e-02 | 3.87e-02 | -1.96e-01 |
| LUSC | cg00946598 | chr1:43651422 | CGI:chr1:43649945-43650638 | promoter,gene body | 5.22e-01 | 6.56e-01 | -2.65e+00 | 8.01e-03 | 1.17e-02 | -1.35e-01 |
| BLCA | cg00946598 | chr1:43651422 | CGI:chr1:43649945-43650638 | promoter,gene body | 4.57e-01 | 6.52e-01 | -2.79e+00 | 5.30e-03 | 8.53e-03 | -1.95e-01 |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| COAD | cg00946598 | chr1:43651422 | CGI:chr1:43649945-43650638 | promoter,gene body | 5.20e-01 | 3.58e-01 | 2.74e+00 | 6.11e-03 | 1.10e-02 | 1.61e-01 |
| LIHC | cg10958452 | chr1:43648675 | CGI:chr1:43649945-43650638 | promoter | 5.13e-01 | 3.98e-01 | 2.20e+00 | 2.81e-02 | 3.16e-02 | 1.15e-01 |
| LIHC | cg17737314 | chr1:43648684 | CGI:chr1:43649945-43650638 | promoter | 4.31e-01 | 3.28e-01 | 3.33e+00 | 8.65e-04 | 2.02e-03 | 1.04e-01 |
Top |
Exon skipping events with PSI in TCGA for KDM4A |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Landscape of exon skipping events across multiple cancer types. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| COAD | exon_skip_5165 | 2.73e-02 | 1.33e-01 | -5.29e+00 | 1.21e-07 | 2.83e-06 | -1.06e-01 |
Top |
RNA A-to-I editing events in TCGA for KDM4A |
| ∗Please access CAeditome for RNA editing annotation. |
Landscape of RNA editing events across multiple cancer types. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| STAD | KDM4A-003 | chr1_43661541_+ | 4.74e-01 | 2.79e-01 | 2.29e+00 | 2.23e-02 | 4.96e-02 | 1.95e-01 |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for KDM4A |
TFs related to KDM4A.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| MESO | ZNF235 | KDM4A | 2.48e+00 | 4.51e-03 | 3.98e+00 | 9.80e-01 | Female-biased |
| MESO | ZNF418 | KDM4A | 2.18e+00 | 4.89e-04 | 4.27e+00 | 9.90e-01 | Female-biased |
| READ | ZNF418 | KDM4A | 4.13e+00 | 1.45e-02 | 4.87e+00 | 9.82e-01 | Female-biased |
KDM4A related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for KDM4A |
RBPs related to ES in KDM4A.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| UVM | MBNL1 | exon_skip_5172 | 9.89e+00 | 1.31e-03 | 1.04e+01 | 9.97e-01 | Female-biased |
| LUSC | SAMD4A | exon_skip_5165 | 7.84e+00 | 3.13e-03 | 8.31e+00 | 9.90e-01 | Female-biased |
| COAD | SAMD4A | exon_skip_5165 | 8.93e+00 | 9.94e-01 | 8.36e+00 | 1.16e-03 | Male-biased |
| BRCA | SAMD4A | exon_skip_5165 | 8.07e+00 | 1.88e-03 | 9.24e+00 | 9.95e-01 | Female-biased |
| READ | MBNL1 | exon_skip_5172 | 1.04e+01 | 9.94e-01 | 1.00e+01 | 4.95e-03 | Male-biased |
| READ | SAMD4A | exon_skip_5165 | 8.15e+00 | 6.74e-03 | 8.52e+00 | 9.87e-01 | Female-biased |
| PCPG | MBNL1 | exon_skip_5172 | 9.99e+00 | 3.59e-03 | 1.04e+01 | 9.95e-01 | Female-biased |
| MESO | MBNL1 | exon_skip_5172 | 1.00e+01 | 6.23e-03 | 1.04e+01 | 9.92e-01 | Female-biased |
| MESO | SAMD4A | exon_skip_5165 | 8.26e+00 | 9.85e-01 | 7.88e+00 | 7.31e-03 | Male-biased |
| LGG | SAMD4A | exon_skip_5165 | 7.92e+00 | 1.09e-02 | 8.25e+00 | 9.82e-01 | Female-biased |
| GBM | MBNL1 | exon_skip_5172 | 1.01e+01 | 6.21e-03 | 1.05e+01 | 9.92e-01 | Female-biased |
| PAAD | SAMD4A | exon_skip_5165 | 8.16e+00 | 2.67e-03 | 8.57e+00 | 9.91e-01 | Female-biased |
| BLCA | SAMD4A | exon_skip_5165 | 8.60e+00 | 9.88e-01 | 8.18e+00 | 6.15e-03 | Male-biased |
| SKCM | SAMD4A | exon_skip_5165 | 7.79e+00 | 1.50e-03 | 8.37e+00 | 9.92e-01 | Female-biased |
KDM4A related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs7529802 | chr1:48764313:G:A | - | -0.258419573096054 | 0.0144752536974671 | GBM | Female-baised eQTL |
| rs34776682 | chr1:48893853:C:T | - | 0.228921084946788 | 0.0189086196670101 | GBM | Female-baised eQTL |
| rs114263982 | chr1:39474617:C:T | - | 0.2718226739243 | 0.0193007604602344 | LIHC | Female-baised eQTL |
| rs215759 | chr1:37115101:A:T | - | -0.0591709847721059 | 0.0329566916427178 | LUAD | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs433116 | chr1:52707821:T:C | - | 0.0546390849085916 | 0.0190444521247969 | KIRC | Male-baised eQTL |
| rs269289 | chr1:52701479:A:C | - | 0.0544943402838521 | 0.020586738511948 | KIRC | Male-baised eQTL |
| rs269286 | chr1:52703346:A:G | - | 0.0544943402838521 | 0.020586738511948 | KIRC | Male-baised eQTL |
| rs269284 | chr1:52703713:A:C | - | 0.0544943402838521 | 0.020586738511948 | KIRC | Male-baised eQTL |
| rs11205993 | chr1:52705354:T:A | - | 0.0544943402838521 | 0.020586738511948 | KIRC | Male-baised eQTL |
| rs12731266 | chr1:41596413:T:C | - | 0.0956188300724706 | 0.0128321721489932 | LUAD | Male-baised eQTL |
| rs55927556 | chr1:41600820:A:G | - | 0.0956188300724706 | 0.0128321721489932 | LUAD | Male-baised eQTL |
| rs35329209 | chr1:41603855:T:C | - | 0.0956188300724706 | 0.0128321721489932 | LUAD | Male-baised eQTL |
| rs6600383 | chr1:41607717:T:C | - | 0.0956188300724706 | 0.0128321721489932 | LUAD | Male-baised eQTL |
| rs35264252 | chr1:41609055:G:A | - | 0.0956188300724706 | 0.0128321721489932 | LUAD | Male-baised eQTL |
| rs12740722 | chr1:41609596:A:G | - | 0.0956188300724706 | 0.0128321721489932 | LUAD | Male-baised eQTL |
| rs34047384 | chr1:41613867:T:C | - | 0.0933168863515574 | 0.0204315521314395 | LUAD | Male-baised eQTL |
| rs34366948 | chr1:41613864:C:G | - | 0.093240836720278 | 0.0226988771727444 | LUAD | Male-baised eQTL |
| rs7554613 | chr1:41611338:T:C | - | 0.0923288480744462 | 0.0233108793310215 | LUAD | Male-baised eQTL |
| rs12757352 | chr1:41612841:A:G | - | 0.0923288480744462 | 0.0233108793310215 | LUAD | Male-baised eQTL |
| rs34697804 | chr1:41614292:C:G | - | 0.0923288480744462 | 0.0233108793310215 | LUAD | Male-baised eQTL |
| rs68087926 | chr1:41595890:C:T | - | 0.0919571455366434 | 0.024317624572563 | LUAD | Male-baised eQTL |
| rs12732519 | chr1:41598904:C:G | - | 0.0919571455366434 | 0.024317624572563 | LUAD | Male-baised eQTL |
| rs66756906 | chr1:41599109:A:G | - | 0.0919571455366434 | 0.024317624572563 | LUAD | Male-baised eQTL |
| rs67999841 | chr1:41599751:T:A | - | 0.0919571455366434 | 0.024317624572563 | LUAD | Male-baised eQTL |
| rs34174267 | chr1:41605863:T:C | - | 0.0919571455366434 | 0.024317624572563 | LUAD | Male-baised eQTL |
| rs41308258 | chr1:41007611:A:G | - | 0.0885369642080486 | 0.0359665418275463 | LUAD | Male-baised eQTL |
| rs2300648 | chr1:41103816:T:C | - | 0.092173893689109 | 0.038957679084693 | LUAD | Male-baised eQTL |
| rs7555313 | chr1:47844894:T:C | - | 0.0605272667980257 | 0.0334500709481694 | COAD | Male-baised eQTL |
| rs11211621 | chr1:47853843:C:T | - | 0.0612942456978511 | 0.0348753353250636 | COAD | Male-baised eQTL |
| rs12086414 | chr1:47854484:T:A | - | 0.0612942456978511 | 0.0348753353250636 | COAD | Male-baised eQTL |
| rs9787212 | chr1:47856438:T:C | - | 0.0612942456978511 | 0.0348753353250636 | COAD | Male-baised eQTL |
| rs705193 | chr1:34795631:C:G | - | -0.0631191608383142 | 0.0348905023084067 | COAD | Male-baised eQTL |
| rs2105253 | chr1:47852134:A:G | - | 0.0603361115232789 | 0.0410356235700143 | COAD | Male-baised eQTL |
| rs1930576 | chr1:38695003:G:A | - | -0.115086831257765 | 0.0428400681553738 | COAD | Male-baised eQTL |
| rs11211619 | chr1:47847128:T:C | - | 0.0593646394285547 | 0.0433530084326724 | COAD | Male-baised eQTL |
| rs6672059 | chr1:52389375:C:T | - | -0.112551998520873 | 0.0448734762380598 | COAD | Male-baised eQTL |
| rs12137475 | chr1:43821476:C:T | - | 0.0831578350593988 | 0.0465046263970234 | COAD | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
| Gene ID: ENSG00000066135 | |
| CpG Site: cg17737314 | |
| Position to Gene: promoter | |
| Male Effect: - | |
| Female Effect: -0.392482565770137 |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg17737314 | chr1:43648684 | promoter | -0.392482565770137 | 5.93366149185761e-07 | -0.721525591984642 | 5.379014665155225e-11 | KIRP |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of KDM4A |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000066135 | KDM4A | C0025202 | melanoma | 1 | CTD_human |